Experience of NovoSeven administration in management of coagulopathic bleedings after surgical interventions with extracorporeal circulation

類似資料

• Use of NovoSeven(® )in cases with massive bleeding following surgery with extracorporeal circulation
  著者:: Dementieva, I, 等
  出版事項: (2004)
• Experience of NovoSeven administration in the management of severe haemorrhage following cardiac surgery of nonhaemophilic patients
  著者:: Michalska, G, 等
  出版事項: (2007)
• Evaluation of the role of recombinant activated factor VII (NovoSeven) as a rescue haemostatic therapy in postcardiopulmonary bypass surgical patients
  著者:: Chen, Z, 等
  出版事項: (2007)
• Recombinant activated factor VII (rFVIIa-NovoSeven(®)-NovoNordisk) treatment of bleeding complications in intensive care unit
  著者:: Bonadona, A, 等
  出版事項: (2002)
• Efficacy of activated recombinant factor VII (rFVIIa; NovoSeven(®)) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial
  著者:: Thabut, D, 等
  出版事項: (2004)